{
  "ticker": "EW",
  "last_updated": "2025-04-19T08:01:13.559986",
  "retention_years": 3,
  "count": 251,
  "transactions": [
    {
      "id": 73154,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 73114,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 73144,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 73100,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 73119,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 73132,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 52476,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 52482,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 73137,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 73143,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 52429,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 73086,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 52479,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 73140,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 34262,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 52427,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 73084,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 34263,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 34268,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 34272,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 34286,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 34298,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 34299,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 34306,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 34320,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 52428,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 52434,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 52438,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 52452,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 52464,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 52465,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 52472,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 52489,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 73085,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 73091,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 73095,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 73110,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 73124,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 73125,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 73133,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 73151,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 34312,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 52480,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 73141,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 34267,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 34284,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 34291,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 34294,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 34295,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 34314,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 34316,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 52433,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 52450,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 52457,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 52460,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 52461,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 52483,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 52485,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 73090,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 73108,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 73116,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 73120,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 73121,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 73145,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 73147,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 34266,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 34271,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 34277,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 34282,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 34304,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 34310,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 34311,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 34313,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 34318,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 34321,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 52432,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 52437,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 52443,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 52448,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 52470,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 52477,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 52478,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 52481,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 52487,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 52490,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 73089,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 73094,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 73101,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 73106,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 73130,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 73138,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 73139,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 73142,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 73149,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 73152,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 34264,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 34269,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 34285,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 34289,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 34290,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 34297,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 34305,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 34315,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 34319,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 52430,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 52435,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 52451,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 52455,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 52456,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 52463,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 52471,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 52484,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 52488,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 73087,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 73092,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 73109,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 73113,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 73115,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 73123,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 73131,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 73146,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 73150,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 34274,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 52440,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 73097,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 34322,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 52491,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 73153,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 34288,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 52454,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 73112,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 19864,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 34309,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 52475,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 73136,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 19848,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 19855,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 34276,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 34292,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 52442,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 52458,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 73099,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 73117,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 19845,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 34270,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 52436,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 73093,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 19863,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 34308,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 52474,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 73135,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 8486,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 19866,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 34323,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 52492,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 73155,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 8480,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 19858,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 34300,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 52466,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 73126,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 8482,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 19860,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 34302,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 52468,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 73128,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 8469,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 19844,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 34265,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 52431,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 73088,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 8472,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 19849,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 34278,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 52444,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 73102,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 8479,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 19857,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 34296,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 52462,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 73122,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 8475,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 8481,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 19852,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 19859,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 34281,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 34301,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 52447,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 52467,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 73105,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 73127,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 1587,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 8471,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 19847,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 34275,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 52441,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 73098,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 1591,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 1592,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 1593,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 8477,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 8478,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 8483,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 19854,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 19856,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 19861,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 34287,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 34293,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 34303,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 52453,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 52459,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 52469,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 73111,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 73118,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 73129,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 1589,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 1590,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 8474,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 8476,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 19851,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 19853,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 34280,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 34283,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 52446,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 52449,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 73104,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 73107,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 1594,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 8484,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 19862,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 34307,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 52473,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 73134,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 1588,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 8473,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 19850,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 34279,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 52445,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 73103,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 1586,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 8470,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 19846,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 34273,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 52439,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 73096,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 1595,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 8485,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 19865,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 34317,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 52486,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 73148,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    }
  ]
}